Edgewise Therapeutics Announces Inducement Grants for New Employees Under Nasdaq Regulations #United_States #biopharmaceuticals #Boulder #Edgewise_Therapeutics #EWTX

Edgewise Therapeutics Announces Inducement Grants for New Employees Under Nasdaq Regulations #United_States #biopharmaceuticals #Boulder #Edgewise_Therapeutics #EWTX
#EWTX Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
#EWTX Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500